<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>MEN • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="MEN • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/MEN/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/MEN/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="men" tabindex="-1">MEN</h1>
<!-- MEN types -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/image-20200123200131073.png" alt=""></p>
<!-- MEN 2 MTC management -->
<p><strong>Multiple endocrine neoplasia type 2 (MEN 2)</strong> is an autosomal dominant disorder caused by germline mutations involving the <em>RET</em> proto-oncogene located on chromosome 10. MEN 2 can be divided into 3  classifications: MEN 2A, MEN 2B, and familial medullary thyroid cancer  (FMTC). <strong>MEN 2A</strong> predisposes to <strong>medullary thyroid cancer (MTC)</strong>, <strong>pheochromocytoma (PCC)</strong>, and <strong>hyperparathyroidism</strong> (due to parathyroid hyperplasia or multiple adenomas). <strong>MEN 2B</strong> is not accompanied by hyperparathyroidism but may be associated with  marfanoid habitus, mucosal neuromas, and skeletal deformations (eg,  kyphoscoliosis, lordosis). FMTC is a subset of MEN 2A associated with  MTC only, without PCC or parathyroid disease.</p>
<p>All patients with MTC require serum calcitonin and carcinoembryonic  antigen, neck ultrasound (evaluation for regional metastases), genetic  testing for germline <em>RET</em> mutations, and evaluation for  coexisting tumors (hyperparathyroidism, PCCs). PCC is present in  approximately 40% of patients with MEN 2, and undiagnosed PCC can cause  life-threatening <strong>hemodynamic complications</strong> during and after thyroid surgery. <strong>Plasma-free metanephrines</strong> are usually elevated in PCC and confirmed with 24-hour urinary  fractionated metanephrines, catecholamines, and abdominal imaging. Once PCC has been ruled out, patients with nonmetastatic MTC may proceed to  thyroidectomy for definitive management.</p>
<p>Anticancer drugs and external beam radiation do not play a role in  initial management of MTC. Radiotherapy is usually reserved for  postsurgery patients with extrathyroidal disease or extensive nodal  metastases not amenable to surgical resection. Chemotherapy is  considered for patients with progressively metastatic MTC not responsive to surgery or radiotherapy.</p>
<p>Radioactive iodine is preferentially taken up by thyroid tissue and is  often used following surgery for patients with differentiated thyroid  cancer (papillary or follicular) who are at risk for recurrence.  Radioactive iodine is not effective for MTC as these cells do not take  up iodine.</p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/Endocrine/" class="peer">Endocrine</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="endocrine" tabindex="-1">Endocrine</h1>
<ul>
<li>related: <a href="/wiki/notes/Medicine/">Medicine</a></li>
</ul>
<h2 id="mksap" tabindex="-1">MKSAP</h2>
<ul>
<li><a href="/wiki/notes/Disorders%20of%20Glucose%20Metabolism/">Disorders of Glucose Metabolism</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Pituitary%20Gland/">Disorders of the Pituitary Gland</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Adrenal%20Glands/">Disorders of the Adrenal Glands</a></li>
<li><a href="/wiki/notes/Disorders%20of%20the%20Thyroid%20Gland/">Disorders of the Thyroid Gland</a></li>
<li><a href="/wiki/notes/Reproductive%20Disorders/">Reproductive Disorders</a></li>
<li><a href="/wiki/notes/Transgender%20Hormone%20Therapy%20Management/">Transgender Hormone Therapy Management</a></li>
<li><a href="/wiki/notes/Calcium%20and%20Bone%20Disorders/">Calcium and Bone Disorders</a></li>
</ul>
<h2 id="pituitary" tabindex="-1">Pituitary</h2>
<ul>
<li><a href="/wiki/notes/pituitary%20adenoma/">pituitary adenoma</a></li>
<li><a href="/wiki/notes/inappropriately%20normal%20TSH%20could%20be%20sign%20of%20central%20hypothyroidism/">inappropriately normal TSH could be sign of central hypothyroidism</a></li>
<li><a href="/wiki/notes/pituitary%20apoplexy/">pituitary apoplexy</a></li>
<li><a href="/wiki/notes/MEN/">MEN</a></li>
<li><a href="/wiki/notes/hyperprolactinemia/">hyperprolactinemia</a></li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
